Press release content from Business Wire. The AP news staff was not involved in its creation.
Court Rules in Favor of Tejon Ranch and Kern County Regarding Re-Approval of Grapevine at Tejon Ranch Master Planned Community
January 22, 2021 GMT
TEJON RANCH, Calif. (BUSINESS WIRE) Jan 22, 2021
Kern County Superior Court Judge Kenneth C. Twisselman today rejected, in its entirety, the most recent lawsuit filed by the Center for Biological Diversity (CBD), a Tucson, Arizona-based extremist environmental organization, that challenged Kern County’s December 2019 re-approval of Grapevine at Tejon Ranch, a master planned mixed use residential community.
In December 2016, the Kern County Board of Supervisors unanimously approved Grapevine. CBD sued the following year, and subsequently lost six of the seven issues it raised regarding the sufficiency of the project’s environmental impact report. On the seventh issue the court ruled that there was a deficiency regarding the internal capt
Flexion Therapeutics Announces Preliminary, Unaudited Fourth-Quarter and Full-Year 2020 Results
Fourth-quarter 2020 ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) net sales estimated to be approximately $26.3 million
Full-year 2020 net sales estimated to be approximately $85.5 million
Company names Adam Muzikant, Ph.D., Chief Business Officer
BURLINGTON, Mass., Jan. 13, 2021 (GLOBE NEWSWIRE) Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced preliminary and unaudited net sales for the fourth quarter and full year ended December 31, 2020.
“We are very pleased to report preliminary full-year 2020 ZILRETTA net sales of approximately $85.5 million,” said Michael Clayman, M.D., President and Chief Executive Officer. “Our strong sales reflect the expanding role ZILRETTA is taking in the osteoarthritis knee pain treatment paradigm. We are encouraged by our commercial performance despite the impacts of the pandemic, and our confidence in
News Category Global Banking & Finance Reviews
UTHealth in Houston and Athersys Announce Commencement of Patient Enrollment in a Phase 2 Trial Evaluating MultiStem® Cell Therapy in Trauma
UTHealth in Houston and Athersys Announce Commencement of Patient Enrollment in a Phase 2 Trial Evaluating MultiStem® Cell Therapy in Trauma The University of Texas Health Science Center at Houston (UTHealth) and Athersys, Inc. (NASDAQ: ATHX) announced today that the first patient has been enrolled in a clinical study evaluating MultiStem cell therapy for the potential early treatment of traumatic injuries and the subsequent complications that result. The MATRICS-1 (MultiStem Administration for Trauma Related Inflammation and Complications) study is being conducted at Memorial Hermann-Texas Medical Center, one of the busiest Level 1 trauma centers in the United States.
Veracyte Announces Expansion of Collaboration with the Lung Cancer Initiative at Johnson & Johnson
Veracyte Announces Expansion of Collaboration with the Lung Cancer Initiative at Johnson & Johnson
Veracyte, Inc. (Nasdaq: VCYT) today announced it has expanded its long-term strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson
1. The collaboration will include a focus on the NOBLE trial, a 9,000-patient, prospective, multicenter clinical study designed to distinguish genomic and other differences in lung cancer development and progression among patients with lung nodules detected by CT imaging. As Veracyte plans for the 2021 launch of the first noninvasive nasal swab test to guide the work-up of patients with potentially cancerous lung nodules, this new study will position the company to develop future tests that benefit broader patient populations, including nonsmokers and those with pre-cancerous changes who are likely to develop lung cancer.
Wolters Kluwer N.V.: Wolters Kluwer completes acquisition of eOriginal
December 16, 2020 - Wolters Kluwer today announces that it has completed the acquisition of eOriginal, as originally
announcedon December 10, 2020. -
About Wolters Kluwer
Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the healthcare; tax and accounting; governance, risk and compliance; and legal and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services. Wolters Kluwer reported 2019 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Eurone